Stocksigma LogoStocksigma Logo

USFDA Concludes Inspection at Zydus' USA Office with Nil Observations

The USFDA conducted an on-site inspection of the pharmacovigilance and post-marketing surveillance systems at Zydus Lifesciences Limited's office located

USFDA Concludes Inspection at Zydus' USA Office with Nil Observations

Zydus Lifesciences Ltd 路 Press Release 路 26 Sept 2026, 5:57 pm

USFDA Concludes Inspection at Zydus' USA Office with Nil Observations The USFDA conducted an on-site inspection of the pharmacovigilance and post-marketing surveillance systems at Zydus Lifesciences Limited's office located in New Jersey, USA. The regulatory audit took place from 22nd Sep'26 to 25th Sep'26 and concluded successfully with nil observations, reaffirming regulatory compliance for the company's US operations.

Original exchange filing (PDF)

More announcements from Zydus Lifesciences Ltd

All Zydus Lifesciences Ltd announcements